HHS Report Highlights Potential Risks of Medical Treatments for Transgender Youth

A new report from the U.S. Department of Health and Human Services (HHS) has identified potential risks associated with medical treatments for gender-dysphoric youth. These treatments, sometimes called "gender-affirming care," can include puberty blockers and hormone therapy. The report advises careful consideration of these procedures for minors. It states that the evidence for the long-term benefits of such treatments remains limited. This assessment comes as the debate over transgender healthcare continues in the United States. The topic remains a prominent legal and political issue.